Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility Study of the Role of Stereotactic Body Radiotherapy for the Treatment of Early Stage Breast Cancer

NCT02065960 is registered in ClinicalTrials.gov with Juravinski Cancer Center as lead sponsor.

NCT NCT02065960
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02065960 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility Study of the Role of Stereotactic Body Radiotherapy for the Treatment of Early Stage Breast Cancer
Lead sponsor
Juravinski Cancer Center
Phase
Phase 1
Overall status
Unknown status
Start date
February 28, 2014
Completion date
June 30, 2020
Enrollment
32 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast neoplasm